Your account is not claimed yet. You can sign up with ORCID to claim your account.

Pedro Romero (Petra Baumgaertner)

ResearcherID ORCID

Publication Activity (10 Years)

Years Active: 2018-2023
Publications (10 Years): 26

Top Venues

Nature immunology

Cancer research

Clinical cancer research : an official journal of the American Association for Cancer Research

Cancer immunology research

University of Lausanne

This page only lists publications with an associated author ORCID identifier.

Affiliation History

University of Lausanne

Switzerland

Professor :: Deapartment of Fundamental Oncology

Publications

Jesus Corria-Osorio, Santiago J Carmona, Evangelos Stefanidis, Massimo Andreatta, Yaquelin Ortiz-Miranda, Tania Muller, Ioanna A Rota, Isaac Crespo, Bili Seijo, Wilson Castro, Cristina Jimenez-Luna, Leonardo Scarpellino, Catherine Ronet, Aodrenn Spill, Evripidis Lanitis, Pedro Romero, Sanjiv A Luther, Melita Irving, George Coukos
Orthogonal cytokine engineering enables novel synthetic effector states escaping canonical exhaustion in tumor-rejecting CD8 + T cells. Nature immunology 24 (5) (2023)
Jesus Corria-Osorio, Santiago J Carmona, Evangelos Stefanidis, Massimo Andreatta, Yaquelin Ortiz-Miranda, Tania Muller, Ioanna A Rota, Isaac Crespo, Bili Seijo, Wilson Castro, Cristina Jimenez-Luna, Leonardo Scarpellino, Catherine Ronet, Aodrenn Spill, Evripidis Lanitis, Pedro Romero, Sanjiv A Luther, Melita Irving, George Coukos
Orthogonal cytokine engineering enables novel synthetic effector states escaping canonical exhaustion in tumor-rejecting CD8 + T cells. Nature immunology 24 (5) (2023)
Jesus Corria-Osorio, Santiago J Carmona, Evangelos Stefanidis, Massimo Andreatta, Yaquelin Ortiz-Miranda, Tania Muller, Ioanna A Rota, Isaac Crespo, Bili Seijo, Wilson Castro, Cristina Jimenez-Luna, Leonardo Scarpellino, Catherine Ronet, Aodrenn Spill, Evripidis Lanitis, Pedro Romero, Sanjiv A Luther, Melita Irving, George Coukos
Orthogonal cytokine engineering enables novel synthetic effector states escaping canonical exhaustion in tumor-rejecting CD8 + T cells. Nature immunology (2023)
Alison Jaccard, Tania Wyss, Noelia Maldonado-Pérez, Jan A Rath, Alessio Bevilacqua, Jhan-Jie Peng, Anouk Lepez, Christine Von Gunten, Fabien Franco, Jang-Jaer Lee, Nicolas Camviel, Francisco Martín, Bart Ghesquiere, Denis Migliorini, Caroline Arber, Pedro Romero, Ping-Chih Ho, Mathias Wenes
Reductive carboxylation epigenetically instructs T cell differentiation. Nature (2023)
Jesus Corria-Osorio, Santiago J Carmona, Evangelos Stefanidis, Massimo Andreatta, Yaquelin Ortiz-Miranda, Tania Muller, Ioanna A Rota, Isaac Crespo, Bili Seijo, Wilson Castro, Cristina Jimenez-Luna, Leonardo Scarpellino, Catherine Ronet, Aodrenn Spill, Evripidis Lanitis, Pedro Romero, Sanjiv A Luther, Melita Irving, George Coukos
Orthogonal cytokine engineering enables novel synthetic effector states escaping canonical exhaustion in tumor-rejecting CD8 + T cells. Nature immunology 24 (5) (2023)
Jesus Corria-Osorio, Santiago J Carmona, Evangelos Stefanidis, Massimo Andreatta, Yaquelin Ortiz-Miranda, Tania Muller, Ioanna A Rota, Isaac Crespo, Bili Seijo, Wilson Castro, Cristina Jimenez-Luna, Leonardo Scarpellino, Catherine Ronet, Aodrenn Spill, Evripidis Lanitis, Pedro Romero, Sanjiv A Luther, Melita Irving, George Coukos
Orthogonal cytokine engineering enables novel synthetic effector states escaping canonical exhaustion in tumor-rejecting CD8 + T cells. Nature immunology 24 (5) (2023)
Aude Boulay, Sara Trabanelli, Stéphanie Boireau, Myriam Boyer-Clavel, Sébastien Nisole, Pedro Romero, Camilla Jandus, Anne-Sophie Beignon, Nathalie Jane Arhel
Assessing the Impact of Persistent HIV Infection on Innate Lymphoid Cells Using In Vitro Models. ImmunoHorizons 7 (3) (2023)
Jesus Corria-Osorio, Santiago J Carmona, Evangelos Stefanidis, Massimo Andreatta, Yaquelin Ortiz-Miranda, Tania Muller, Ioanna A Rota, Isaac Crespo, Bili Seijo, Wilson Castro, Cristina Jimenez-Luna, Leonardo Scarpellino, Catherine Ronet, Aodrenn Spill, Evripidis Lanitis, Pedro Romero, Sanjiv A Luther, Melita Irving, George Coukos
Orthogonal cytokine engineering enables novel synthetic effector states escaping canonical exhaustion in tumor-rejecting CD8 + T cells. Nature immunology 24 (5) (2023)
Jesus Corria-Osorio, Santiago J Carmona, Evangelos Stefanidis, Massimo Andreatta, Yaquelin Ortiz-Miranda, Tania Muller, Ioanna A Rota, Isaac Crespo, Bili Seijo, Wilson Castro, Cristina Jimenez-Luna, Leonardo Scarpellino, Catherine Ronet, Aodrenn Spill, Evripidis Lanitis, Pedro Romero, Sanjiv A Luther, Melita Irving, George Coukos
Orthogonal cytokine engineering enables novel synthetic effector states escaping canonical exhaustion in tumor-rejecting CD8 + T cells. Nature immunology (2023)
Jesus Corria-Osorio, Santiago J Carmona, Evangelos Stefanidis, Massimo Andreatta, Yaquelin Ortiz-Miranda, Tania Muller, Ioanna A Rota, Isaac Crespo, Bili Seijo, Wilson Castro, Cristina Jimenez-Luna, Leonardo Scarpellino, Catherine Ronet, Aodrenn Spill, Evripidis Lanitis, Pedro Romero, Sanjiv A Luther, Melita Irving, George Coukos
Orthogonal cytokine engineering enables novel synthetic effector states escaping canonical exhaustion in tumor-rejecting CD8 + T cells. Nature immunology (2023)
Jesus Corria-Osorio, Santiago J Carmona, Evangelos Stefanidis, Massimo Andreatta, Yaquelin Ortiz-Miranda, Tania Muller, Ioanna A Rota, Isaac Crespo, Bili Seijo, Wilson Castro, Cristina Jimenez-Luna, Leonardo Scarpellino, Catherine Ronet, Aodrenn Spill, Evripidis Lanitis, Pedro Romero, Sanjiv A Luther, Melita Irving, George Coukos
Orthogonal cytokine engineering enables novel synthetic effector states escaping canonical exhaustion in tumor-rejecting CD8 + T cells. Nature immunology (2023)
Amélie Cachot, Mariia Bilous, Yen-Cheng Liu, Xiaokang Li, Margaux Saillard, Mara Cenerenti, Georg Alexander Rockinger, Tania Wyss Lozano, Philippe Guillaume, Julien Schmidt, Raphaël Genolet, Giuseppe Ercolano, Maria Pia Protti, Walter Reith, Kalliopi Ioannidou, Laurence de Leval, Joseph A Trapani, George Coukos, Alexandre Harari, Daniel E Speiser, Alexander Mathis, David Gfeller, Hatice Altug, Pedro Romero, Camilla Jandus
Tumor-specific cytolytic CD4 T cells mediate immunity against human cancer. Science advances 7 (9) (2021)
Giuseppe Ercolano, Alejandra Gomez-Cadena, Nina Dumauthioz, Giulia Vanoni, Mario Kreutzfeldt, Tania Wyss, Liliane Michalik, Romain Loyon, Angela Ianaro, Ping-Chih Ho, Christophe Borg, Manfred Kopf, Doron Merkler, Philippe Krebs, Pedro Romero, Sara Trabanelli, Camilla Jandus
PPARɣ drives IL-33-dependent ILC2 pro-tumoral functions. Nature communications 12 (1) (2021)
Sara Labiano, Vincent Roh, Céline Godfroid, Agnès Hiou-Feige, Jackeline Romero, Eva Sum, Moritz Rapp, Gael Boivin, Tania Wyss Lozano, Christian Simon, Jean Bourhis, Pablo Umaña, Christine Trumpfheller, Genrich V Tolstonog, Marie-Catherine Vozenin, Pedro Romero
CD40 Agonist Targeted to Fibroblast Activation Protein α Synergizes with Radiotherapy in Murine HPV-Positive Head and Neck Tumors. Clinical cancer research : an official journal of the American Association for Cancer Research 27 (14) (2021)
Christof B Wyss, Nathalie Duffey, Sanam Peyvandi, David Barras, Amaia Martinez-Usatorre, Oriana Coquoz, Pedro Romero, Mauro Delorenzi, Girieca Lorusso, Curzio Ruegg
Gain of HIF1 Activity and Loss of miRNA let-7d Promote Breast Cancer Metastasis to the Brain via the PDGF/PDGFR Axis. Cancer research 81 (3) (2021)
Eva Sum, Moritz Rapp, Philipp Fröbel, Marine Le Clech, Harald Dürr, Anna Maria Giusti, Mario Perro, Dario Speziale, Leo Kunz, Elena Menietti, Peter Brünker, Ulrike Hopfer, Martin Lechmann, Andrzej Sobieniecki, Birte Appelt, Roberto Adelfio, Valeria Nicolini, Anne Freimoser-Grundschober, Whitney Jordaan, Sara Labiano, Felix Weber, Thomas Emrich, François Christen, Birgit Essig, Pedro Romero, Christine Trumpfheller, Pablo Umaña
Fibroblast Activation Protein α-Targeted CD40 Agonism Abrogates Systemic Toxicity and Enables Administration of High Doses to Induce Effective Antitumor Immunity. Clinical cancer research : an official journal of the American Association for Cancer Research 27 (14) (2021)
Yugang Guo, Yu-Qing Xie, Min Gao, Yang Zhao, Fabien Franco, Mathias Wenes, Imran Siddiqui, Alessio Bevilacqua, Haiping Wang, Hanshuo Yang, Bing Feng, Xin Xie, Catherine M Sabatel, Benjamin Tschumi, Amphun Chaiboonchoe, Yuxi Wang, Weimin Li, Weihua Xiao, Werner Held, Pedro Romero, Ping-Chih Ho, Li Tang
Metabolic reprogramming of terminally exhausted CD8+ T cells by IL-10 enhances anti-tumor immunity. Nature immunology 22 (6) (2021)
Pedro Romero, Alena Donda, Jeffrey A Hubbell
An optimized antigen-protein fusion. Nature biomedical engineering 4 (6) (2020)
Giuseppe Ercolano, Andrea Garcia-Garijo, Bérengère Salomé, Alejandra Gomez-Cadena, Giulia Vanoni, Beatris Mastelic-Gavillet, Angela Ianaro, Daniel E Speiser, Pedro Romero, Sara Trabanelli, Camilla Jandus
Immunosuppressive Mediators Impair Proinflammatory Innate Lymphoid Cell Function in Human Malignant Melanoma. Cancer immunology research 8 (4) (2020)
Fabien Franco, Alison Jaccard, Pedro Romero, Yi-Ru Yu, Ping-Chih Ho
Metabolic and epigenetic regulation of T-cell exhaustion. Nature metabolism 2 (10) (2020)
Carla Costa-Nunes, Amélie Cachot, Sara Bobisse, Marion Arnaud, Raphael Genolet, Pedro Romero, Daniel E Speiser, Pedro M Sousa Alves, Federico Sandoval, Olivier Adotévi, Walter Reith, Maria Pia Protti, George Coukos, Alexandre Harari, Camilla Jandus
High-throughput Screening of Human Tumor Antigen-specific CD4 T Cells, Including Neoantigen-reactive T Cells. Clinical cancer research : an official journal of the American Association for Cancer Research 25 (14) (2019)
Amaia Martinez-Usatorre, Lorenzo F Sempere, Santiago J Carmona, Laura Carretero-Iglesia, Gwennaëlle Monnot, Daniel E Speiser, Nathalie Rufer, Alena Donda, Dietmar Zehn, Camilla Jandus, Pedro Romero
MicroRNA-155 Expression Is Enhanced by T-cell Receptor Stimulation Strength and Correlates with Improved Tumor Control in Melanoma. Cancer immunology research 7 (6) (2019)
Quentin Haas, Kayluz Frias Boligan, Camilla Jandus, Christoph Schneider, Cedric Simillion, Michal A Stanczak, Monika Haubitz, Seyed Morteza Seyed Jafari, Alfred Zippelius, Gabriela M Baerlocher, Heinz Laubli, Robert E Hunger, Pedro Romero, Hans-Uwe Simon, Stephan von Gunten
Siglec-9 Regulates an Effector Memory CD8+ T-cell Subset That Congregates in the Melanoma Tumor Microenvironment. Cancer immunology research 7 (5) (2019)
Laia Martínez-Carreres, Julien Puyal, Lucia Carolina Leal-Esteban, Meritxell Orpinell, Judit Castillo-Armengol, Albert Giralt, Oleksandr Dergai, Catherine Moret, Valentin Barquissau, Anita Nasrallah, Angélique Pabois, Lianjun Zhang, Pedro Romero, Isabel C Lopez-Mejia, Lluis Fajas
CDK4 Regulates Lysosomal Function and mTORC1 Activation to Promote Cancer Cell Survival. Cancer research 79 (20) (2019)
Christine Pich-Bavastro, Patrick Meylan, Beatris Mastelic-Gavillet, Thanh Nhan Nguyen, Romain Loyon, Bao Khanh Trang, Hélène Moser, Catherine Moret, Christine Goepfert, Jürg Hafner, Mitchell P Levesque, Pedro Romero, Camilla Jandus, Liliane Michalik
Induction of Paracrine Signaling in Metastatic Melanoma Cells by PPARγ Agonist Rosiglitazone Activates Stromal Cells and Enhances Tumor Growth. Cancer research 78 (22) (2018)
Amaia Martínez-Usatorre, Alena Donda, Dietmar Zehn, Pedro Romero
PD-1 Blockade Unleashes Effector Potential of Both High- and Low-Affinity Tumor-Infiltrating T Cells. Journal of immunology (Baltimore, Md. : 1950) 201 (2) (2018)

Pedro Romero.css-eqlu8i{font-size:small;padding-left:4px;} (Petra Baumgaertner)

Publication Activity (10 Years)

Top Topics

Top Venues

Pedro Romero (Petra Baumgaertner)